This week's research ethics roundup covers efforts by Black scientists to develop oxygen sensors for darker skin; the ethical challenges faced by clinical ethicists; new policy guidance for immediate open access to research findings; and the use of electronic health record data to study pregnancy outcomes. Read more
TAG ARCHIVES FOR open access
The emperor has no clothesTags:
by Julie Fine, BS, legal specialist, Legal Division, Worldwide Research and Development, Pfizer Inc. (Please note: The views presented here are my own and do not reflect the positions or policies of Pfizer, Inc.)
During lunch on Tuesday, I took advantage of the opportunity to join other conference attendees for an intimate and informal question and answer session with Keynote Speaker, Read more
Ethics CORE: A New Home for Ethics on the WebTags:
by Megan Hayes Mahoney, Visiting Digital Library Research Librarian at the University of Illinois at Urbana-Champaign
In 2010, the University of Illinois at Urbana-Champaign (UIUC) began work on a multi-year project designed to make ethics information and training resources readily accessible to those working in the fields of science and engineering. PRIM&R was honored to be a part of the effort, which was supported by a grant awarded to UIUC by the National Science Foundation (NSF). PRIM&R contributed encyclopedia entries for commonly used terms in human subjects and animal research, as well as a listing of exemplary research forms, policies, manuals, and checklists related [...] Read more
Research Ethics Roundup: Free access to research, new policies in Europe, and more!Tags:
Recent changes to clinical trial rules in Europe, an emerging controversy over Food and Drug Administration (FDA)-approved anemia drugs, and heated debate over the bird flu moratorium are all in the mix in this week’s Research Ethics Roundup.
Europe proposes revision of clinical trial rules: The European Commission has formally adopted proposals for new rules to replace the controversial Clinical Trials Directive. Experts predict that these changes will reduce some of the red tape that has resulted in bloated insurance costs and a reduction in the number of clinical trials being conducted in the EU since the inception of the directive.